This inventor holds 1 USPTO granted patent. Top assignee: New York University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: John O'bryan: Innovator in Oncogenic Signaling
Introduction
John O'bryan is a notable inventor based in Charleston, SC (US). He has made significant contributions to the field of cancer research through his innovative work. His research focuses on targeting oncogenic signaling pathways, which are crucial in the development of cancer.
Latest Patents
O'bryan holds a patent titled "Compositions and Methods Targeting the Nucleotide Free State of Ras to Block Oncogenic Signaling and Transformation." This patent represents a breakthrough in understanding how to inhibit cancer cell growth by manipulating specific molecular pathways.
Career Highlights
John O'bryan is affiliated with New York University, where he conducts his research. His work has garnered attention for its potential applications in cancer treatment and therapy. With 1 patent to his name, he continues to push the boundaries of scientific innovation.
Collaborations
O'bryan collaborates with esteemed colleagues, including Shohei Koide and Akiko Koide. Their combined expertise enhances the research efforts and contributes to the advancement of knowledge in the field.
Conclusion
John O'bryan's contributions to cancer research through his innovative patent highlight the importance of scientific inquiry in addressing complex health challenges. His work exemplifies the impact that dedicated inventors can have on society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile